Related Experiment Video
Updated: Jun 7, 2025
09:01
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
296
The UBA1-STUB1 Axis Mediates Cancer Immune Escape and Resistance to Checkpoint Blockade
Yi Bao1,2, Gabriel Cruz1,2, Yuping Zhang1,2
1Michigan Center for Translational Pathology, University of Michigan, Ann Arbor, Michigan.
Cancer Discovery
|November 14, 2024
Summary
UBA1 is a biomarker predicting outcomes in cancer immunotherapy. Inhibiting UBA1 via JAK1 stabilization may overcome immune evasion and improve treatment effectiveness.
Area of Science:
- Oncology
- Immunology
- Biochemistry
Background:
- Immune checkpoint blockade (ICB) therapy shows promise but faces challenges with resistance.
- Cancer immune evasion mechanisms limit the efficacy of current immunotherapies.
Purpose of the Study:
- To identify biomarkers predicting clinical outcomes in ICB-treated patients.
- To elucidate mechanisms of ICB resistance and explore novel therapeutic targets.
Main Methods:
- Analysis of UBA1 expression in ICB cohorts.
- Investigation of UBA1's role in cancer immune evasion.
- Exploration of UBA1 inhibition mechanisms, including JAK1 stabilization.
- Assessment of the UBA1-STUB1 axis as a therapeutic target.
Main Results:
- UBA1 identified as a predictive biomarker for clinical outcomes in ICB cohorts.
- UBA1 found to mediate cancer immune evasion and ICB resistance.
- JAK1 stabilization demonstrated as a key mechanism for UBA1 inhibition.
Conclusions:
- UBA1 is a significant biomarker for predicting response to cancer immunotherapy.
- Targeting the UBA1-STUB1 axis offers a potential strategy to enhance ICB efficacy.
- Understanding UBA1's role provides new avenues for overcoming treatment resistance.
Related Concept Videos
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
01:27Tumor Immunotherapy
480
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
480
01:35Cancer Cell Migration through Invadopodia
2.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
01:31The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
02:07Tumor Progression
6.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.2K